Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Plos Pathogens
|
September 22, 2020
The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis
Terry W Bilverstone, Megan Garland, Rory J Cave, et al.
Biotechnology Journal
|
May 24, 2016
CRISPR-based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii
Qi Li, Jun Chen, Nigel P Minton, et al.
Proteomics
|
March 29, 2002
A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics
Daniel I R Spencer, Lynda Robson, Des Purdy, et al.
Vaccine
|
June 20, 2006
Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge
Julia Vipond, Richard Vipond, Emma Allen-Vercoe, et al.
Frontiers in Cellular and Infection Microbiology
|
January 10, 2017
Functional Intestinal Bile Acid 7α-Dehydroxylation by <i>Clostridium scindens</i> Associated with Protection from <i>Clostridium difficile</i> Infection in a Gnotobiotic Mouse Model
Nicolas Studer, Lyne Desharnais, Markus Beutler, et al.
Plos Pathogens
|
November 13, 2023
A sporulation signature protease is required for assembly of the spore surface layers, germination and host colonization in Clostridioides difficile
Eleonora Marini, Carmen Olivença, Sara Ramalhete, et al.
Nature Communications
|
February 19, 2021
Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
Pablo Castro-Córdova, Paola Mora-Uribe, Rodrigo Reyes-Ramírez, et al.
Nature Communications
|
April 29, 2022
Author Correction: Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
Pablo Castro-Córdova, Paola Mora-Uribe, Rodrigo Reyes-Ramírez, et al.
Cancer Gene Therapy
|
February 9, 2021
Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours
Alexandra M Mowday, Ludwig J Dubois, Aleksandra M Kubiak, et al.
Nature Microbiology
|
August 31, 2016
The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
Carrie A Cowardin, Erica L Buonomo, Mahmoud M Saleh, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Plos Pathogens
|
September 22, 2020
The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis
Terry W Bilverstone, Megan Garland, Rory J Cave, et al.
Biotechnology Journal
|
May 24, 2016
CRISPR-based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii
Qi Li, Jun Chen, Nigel P Minton, et al.
Proteomics
|
March 29, 2002
A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics
Daniel I R Spencer, Lynda Robson, Des Purdy, et al.
Vaccine
|
June 20, 2006
Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge
Julia Vipond, Richard Vipond, Emma Allen-Vercoe, et al.
Frontiers in Cellular and Infection Microbiology
|
January 10, 2017
Functional Intestinal Bile Acid 7α-Dehydroxylation by <i>Clostridium scindens</i> Associated with Protection from <i>Clostridium difficile</i> Infection in a Gnotobiotic Mouse Model
Nicolas Studer, Lyne Desharnais, Markus Beutler, et al.
Plos Pathogens
|
November 13, 2023
A sporulation signature protease is required for assembly of the spore surface layers, germination and host colonization in Clostridioides difficile
Eleonora Marini, Carmen Olivença, Sara Ramalhete, et al.
Nature Communications
|
February 19, 2021
Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
Pablo Castro-Córdova, Paola Mora-Uribe, Rodrigo Reyes-Ramírez, et al.
Nature Communications
|
April 29, 2022
Author Correction: Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection
Pablo Castro-Córdova, Paola Mora-Uribe, Rodrigo Reyes-Ramírez, et al.
Cancer Gene Therapy
|
February 9, 2021
Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours
Alexandra M Mowday, Ludwig J Dubois, Aleksandra M Kubiak, et al.
Nature Microbiology
|
August 31, 2016
The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
Carrie A Cowardin, Erica L Buonomo, Mahmoud M Saleh, et al.
Page
of 17